Tuberculosis News and Research

Latest Tuberculosis News and Research

Researchers identify mechanism to reduce pathogenic effect of bacillus bacteria

A European-Asian collaboration of scientists, notably including CNRS, the Institut Pasteur in Paris, the Institut Pasteur Korea in Seoul (IP Korea/Equipe Avenir Inserm and the Université de Toulouse have identified ten virulence genes of the tubercle bacillus. The inactivation of these genes lessens the pathogenic effects of the bacillus.

16 Sep 2010

Opinions: Global nursing; U.S. funding of Global Fund; Global demands for water; Food security

"Almost every nation, regardless of its wealth and resources, faces a continuing shortage of nurses and an acute lack of nursing faculty available to educate more nurses. This dearth of practicing nurses and nurse educators is particularly critical in countries like Haiti and other developing high-risk, low-resourced nations," Martha Hill, dean of Johns Hopkins School of Nursing, writes in a Baltimore Sun opinion piece encouraging the expansion of global nursing.

15 Sep 2010

Experts to announce new findings on Malaria control

Leading malaria experts, officials and advocates to announce new findings detailed in "Saving Lives with Malaria Control: Counting Down to the Millennium Development Goals," a report published as part of the Roll Back Malaria Partnership's Progress & Impact Series.

14 Sep 2010

Excelimmune presents positive results for HRPA therapy against MRSA infections

Excelimmune, Inc. announced positive results from preclinical studies evaluating the efficacy of its human recombinant polyclonal antibody (HRPA) therapy against infections caused by methicillin-resistant Staphylococcus aureus (MRSA).

14 Sep 2010

AIDS advocates call for African Governments to spend more of their own funds on health

Doctors and AIDS activists on Friday urged African governments to fulfill a decade-old pledge to spend more of their own money on health if they want international help in fighting AIDS.

14 Sep 2010

Accord reached on draft declaration for MDG summit

World powers have reached an accord, after weeks of tough talks, on a document to be adopted at a Millennium Development summit this month for which [U.N.] Secretary General Ban Ki-moon is seeking billions of dollars of new funding,Agence France-Presse reports in an article that describes how representatives from donor and developing nations debated how best to pay for a kick start to the ambitious development goals first set at the Millennium summit in 2000.

13 Sep 2010

395 new vaccines being developed for infectious diseases: PhRMA

Critical challenges remain in the centuries-old battles against infectious diseases, particularly as bacteria and viruses mutate and as the threat of bioterrorism grows. Responding to this need, America's biopharmaceutical research companies this year have 395 new medicines and vaccines in the pipeline to fight infectious diseases. All 395 are in later stages of development, meaning in clinical trials or under Food and Drug Administration (FDA) review.

10 Sep 2010

Summit negotiators seek to get MDGs 'back on track'

"World powers are moving slowly toward an accord on the strategy to be embraced at a looming United Nations summit aiming to get the lofty Millennium Development Goals [MDGs] back on track," Agence France-Presse writes in an article examining the ongoing debates over how best to achieve the MDGs before the 2015 deadline.

10 Sep 2010

Discovery on Mycobacterium tuberculosis can offer new approaches for TB prevention

One third of the world's population is infected with Mycobacterium tuberculosis (MTB), which leads to tuberculosis (TB), a leading cause of death world-wide. A new discovery, led by a team of researchers from Case Western Reserve University School of Medicine, offers hope for new approaches to the prevention and treatment of TB. The team's discovery of a novel mechanism that may contribute to immune recognition of MTB is published in the September issue of Nature Structural and Molecular Biology.

10 Sep 2010

Aethlon Hemopurifier captures immunosuppressive exosomes from individuals with metastatic melanoma.

Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that its researchers have demonstrated the ability of the Aethlon Hemopurifier® to capture immunosuppressive exosomes derived from individuals with metastatic melanoma.

9 Sep 2010

Emergent BioSolutions receives early termination grant to acquire Trubion

Emergent BioSolutions Inc. announced today that the U.S. Department of Justice and Federal Trade Commission granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 ("HSR Act"), as amended, with respect to the planned acquisition of Trubion Pharmaceuticals, Inc. by Emergent BioSolutions announced on August 12, 2010.

9 Sep 2010

Opinions: U.S. commitment to Global Fund; Innovative financing; Global food security; Aid for Pakistan

A Times of Trenton editorial looks at the work of the Global Fund to Fight AIDS, Tuberculosis and Malaria, which is "estimated to have already saved 5 million lives, enables programs that prevent and treat infections, eliminate the transmission of HIV from pregnant women to their unborn children, contain the threat of multidrug-resistant TB, and eliminate malaria as a public health problem."

9 Sep 2010

Emergent BioSolutions initiates Phase I clinical trial for anthrax monoclonal antibody therapeutic

Emergent BioSolutions Inc. announced today that the Phase I clinical trial for its anthrax monoclonal antibody therapeutic has commenced with the dosing of the first subject. Emergent's fully human monoclonal antibody product candidate is being developed as a parenteral post-exposure therapeutic to treat symptoms of inhalational anthrax disease.

8 Sep 2010

Global Fund investigates allegations that donated malaria drugs were stolen, resold in some African countries

After recent research found that some donated malaria drugs are being stolen and sold commercially in several African countries, the Global Fund to Fight AIDS, Tuberculosis and Malaria Communications Director Joe Liden said the group is looking into the situation "in a number of countries," PBS' NewsHour's blog, "The Rundown" reports.

8 Sep 2010

VOA News examines U.S. Global Health Initiative

VOA News examines President Barack Obama's $63 billion Global Health Initiative (GHI), noting the initiative's emphasis on cost-effective strategies to improve child- and maternal-health as well as programs to fight HIV/AIDS, tuberculosis (TB) and malaria. The article includes recent comments by Secretary of State Hillary Rodham Clinton on the role the GHI will play in strengthening health systems and the administration's on-going commitment to global HIV/AIDS programs.

4 Sep 2010

WHO revises treatment protocols for HIV patients

Prompted by clinical research into the early initiation of antiretroviral therapies for HIV performed at the GHESKIO clinic in Port-au-Prince, Haiti, the World Health Organization (WHO) has revised its treatment protocols for HIV patients.

3 Sep 2010

Commitments to global HIV/AIDS programs falter for 'first time in 15 years,' UNAIDS chief says

UNAIDS Executive Director Michel Sidibe "said Thursday that global contributions to fighting [HIV/AIDS] are dropping off for the first time in 15 years amid tough economic times," Agence France-Presse reports.

3 Sep 2010

NEJM publishes study on Xpert MTB/RIF test for rapid molecular detection of TB and rifampin resistance

Cepheid today announced that its Xpert® MTB/RIF test was the subject of a study published in the latest edition of the New England Journal of Medicine (NEJM), "Rapid Molecular Detection of Tuberculosis and Rifampin Resistance." The complete study is now available online (http://www.nejm.org) and will appear in the September 9 print edition.

3 Sep 2010

New TB diagnostic test effective in first large-scale field trial

Research assessing the effectiveness of a new diagnostic test for the detection of tuberculosis (TB) is featured in the Sept. 1 edition of the New England Journal of Medicine.

3 Sep 2010

New test detects TB faster, with more accuracy than current diagnostics, study says

A new molecular test for tuberculosis can diagnose the disease and detect a drug-resistant form of it in less than two hours and more accurately than current tests, according to the findings of a study published online in the New England Journal of Medicine on Wednesday, Reuters reports (Kelland, 9/1).

3 Sep 2010

Tuberculosis News and Research

Latest Tuberculosis News and Research

Researchers identify mechanism to reduce pathogenic effect of bacillus bacteria

Opinions: Global nursing; U.S. funding of Global Fund; Global demands for water; Food security

Experts to announce new findings on Malaria control

Excelimmune presents positive results for HRPA therapy against MRSA infections

AIDS advocates call for African Governments to spend more of their own funds on health

Accord reached on draft declaration for MDG summit

395 new vaccines being developed for infectious diseases: PhRMA

Summit negotiators seek to get MDGs 'back on track'

Discovery on Mycobacterium tuberculosis can offer new approaches for TB prevention

Aethlon Hemopurifier captures immunosuppressive exosomes from individuals with metastatic melanoma.

Emergent BioSolutions receives early termination grant to acquire Trubion

Opinions: U.S. commitment to Global Fund; Innovative financing; Global food security; Aid for Pakistan

Emergent BioSolutions initiates Phase I clinical trial for anthrax monoclonal antibody therapeutic

Global Fund investigates allegations that donated malaria drugs were stolen, resold in some African countries

VOA News examines U.S. Global Health Initiative

WHO revises treatment protocols for HIV patients

Commitments to global HIV/AIDS programs falter for 'first time in 15 years,' UNAIDS chief says

NEJM publishes study on Xpert MTB/RIF test for rapid molecular detection of TB and rifampin resistance

New TB diagnostic test effective in first large-scale field trial

New test detects TB faster, with more accuracy than current diagnostics, study says

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Tuberculosis News and Research

Latest Tuberculosis News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in